Another study demonstrated that silencing Cripto-1 (CR-1) expression in prostate cancer cells, suppressed proliferation, migration, and invasion of these cells through the inhibition of both FAK/Src/PI3K and Wnt/β-catenin signaling pathways [111]. Here, PTK2 is linked to prostate carcinoma.